News

Spectrum Pharmaceuticals (Spectrum) and Handok Pharmaceuticals (Handok) have entered into collaboration for the development and commercialisation of apaziquone in South Korea. Apaziquone is an antineoplastic agent currently being

Inovio Biomedical has reported that a combination of synthetic consensus H1N1, H2N2, H3N2, and H5N1 influenza vaccine candidates achieved protective antibody responses against several different influenza sub-types and

Circassia has reported positive results from a recently completed phase II clinical study of ToleroMune cat allergy therapy, which successfully identified the optimal dosing regimens to progress into

Roche has established Roche Pharma Partnering Asia Office in China on November 1, 2009. The New facility will help create network alliances worldwide. Reportedly, the move is a

Amgen has licensed the exclusive right to use the ImmunoGen’s maytansinoid Targeted Antibody Payload (TAP) technology to develop anticancer therapeutics for an undisclosed target. This is the second

Boston Scientific has received 510(k) clearance from the FDA and CE Mark approval to market its WallFlex fully covered esophageal stent for the treatment of malignant esophageal strictures

Pfizer has received FDA approval for Revatio (sildenafil) injection, an intravenous formulation of Revatio. Revatio is the FDA-approved phosphodiesterase-5 (PDE5) inhibitor available in both tablet and intravenous formulations.

ScinoPharm has received the Potent Compound Safety Certification from SafeBridge Consultants. The company claims that, with a cGMP manufacturing facility designed to manufacture cytotoxic and high potency compounds,

Pozen has initiated the enrollment for the Phase 3 studies for PA32540. PA32540 is a fixed-dose combination of 325mg of enteric coated aspirin and 40mg of immediate release